zintick

Bausch Health Companies BHC

Bausch Health Companies Inc. · NYSE · Pharmaceutical Preparations

$6.92+9.67%close on Oct. 28, 2026 · volume 7.8M · Yahoo Finance

Price, last 47 sessions

$6.00$6.50Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $6.92 · low $5.64 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 19, 2026Aimee J. Lenar
President, US Pharma
Sold
10b5-1 plan
36,827$7.03$258,894

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 7 →
  • 8-KOct. 28, 2026, 4:07 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedBausch Health beats Q3 2026 estimates with adjusted EPS of $1.77 vs $1.24 consensus and raises 2026 revenue guidance to $10.975-11.175 billion

  • 4Oct. 2, 2026, 4:46 p.m. ETView on SEC.gov
  • 4Oct. 2, 2026, 4:27 p.m. ETView on SEC.gov
  • 4Oct. 2, 2026, 4:18 p.m. ETView on SEC.gov
  • 4Aug. 20, 2026, 4:33 p.m. ETView on SEC.gov
  • 10-QJuly 30, 2026, 4:11 p.m. ETView on SEC.gov
  • 8-KJuly 29, 2026, 4:11 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits